mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.5 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |